What is the level of liabilities of Athenex this year?
Athenex has a debt balance of 210.56 M USD this year.
Athenex Liabilities 2024
Athenex Liabilities
210.56 M USD
Ticker
ATNX
ISIN
US04685N1037
WKN
A2DTE9
In 2024, Athenex's total liabilities amounted to 210.56 M USD, a -2.66% difference from the 216.32 M USD total liabilities in the previous year.
Athenex Aktienanalyse
What does Athenex do?
Athenex Inc was founded in 2003 and is headquartered in Buffalo, New York. The company specializes in the development and marketing of innovative drugs and therapies for the treatment of cancer and other serious diseases. Athenex's business model is based on collaboration with other companies and research institutions. The company works closely with academic partners to identify and develop new technologies and active ingredients. Athenex has also entered into several collaboration agreements with major pharmaceutical companies to facilitate the marketing of its products. The company has multiple divisions: Athenex Pharmaceutical Division, Athenex Oncology Division, and Athenex Pharmaceutical Technology Division. The Athenex Pharmaceutical Division focuses on the development and marketing of drugs for the treatment of cancer and other serious illnesses. The company has several promising drug candidates in its pipeline, including Oratopo, a drug for the treatment of breast cancer, and KX-2-391, a drug for the treatment of prostate cancer. The Athenex Oncology Division focuses on the development and marketing of innovative cancer treatment methods. The company has several promising therapy approaches in its pipeline, including an immunological cancer treatment based on activating the immune system to fight cancer cells. The Athenex Pharmaceutical Technology Division utilizes advanced technologies to improve the effectiveness and tolerability of drugs, including novel drug delivery systems and innovative packaging forms. Athenex also offers a wide range of products and services for the pharmaceutical industry, including drug development and manufacturing, as well as the supply of active ingredients and excipients. Overall, Athenex has a broad and interesting business model and a promising portfolio of drug candidates and therapy approaches in its pipeline. The company has also established strong partnerships with other companies and research institutions to advance its development and marketing of drugs and therapies. Athenex ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Athenex's Liabilities
Athenex's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Athenex's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Athenex's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Athenex's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Athenex’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Athenex stock
What were the liabilities of Athenex compared to the previous year?
The liabilities of Athenex have increased by -2.66% dropped compared to the previous year.
What are the consequences of high debt for investors of Athenex?
High liabilities can pose a risk for investors of Athenex, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Athenex?
Low liabilities mean that Athenex has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Athenex affect the company?
An increase in liabilities of Athenex can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Athenex affect the company?
A decrease in the liabilities of Athenex can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Athenex?
Some factors that can influence the liabilities of Athenex include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Athenex so important for investors?
The liabilities of Athenex are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Athenex take to modify the liabilities?
To change its liabilities, Athenex can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Athenex pay?
Over the past 12 months, Athenex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Athenex is expected to pay a dividend of 0 USD.
What is the dividend yield of Athenex?
The current dividend yield of Athenex is .
When does Athenex pay dividends?
Athenex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Athenex?
Athenex paid dividends every year for the past 0 years.
What is the dividend of Athenex?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Athenex located?
Athenex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Athenex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Athenex from 12/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/3/2024.
When did Athenex pay the last dividend?
The last dividend was paid out on 12/3/2024.
What was the dividend of Athenex in the year 2023?
In the year 2023, Athenex distributed 0 USD as dividends.
In which currency does Athenex pay out the dividend?
The dividends of Athenex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Athenex
Our stock analysis for Athenex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Athenex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
